Literature DB >> 4372178

Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

E Norrby, H Link, J E Olsson, M Panelius, A Salmi, B Vandvik.   

Abstract

The occurrence of a local production in the central nervous system (CNS) of antibodies against different selected viruses was analyzed by comparison of titers in serum and cerebrospinal fluid samples from groups of 50 patients with multiple sclerosis from Finland, Norway, and Sweden. Measles antibodies were determined in hemagglutination inhibition, hemolysis inhibition, and nucleocapsid complement fixation tests; mumps, parainfluenza virus type 1, and rubella virus antibodies were determined in hemagglutination inhibition tests; and herpes simplex virus type 1 antibodies were determined in passive hemagglutination tests. For reference purposes tests were also made for adenovirus antibodies in penton hemagglutination enhancement tests and poliovirus antibodies in neutralization enhancement tests. Among the 150 multiple sclerosis patients, a local production of antibodies against measles virus was found in the CNS in 57%, against rubella virus in 19%, mumps virus in 15%, herpes simplex virus type 1 in 11%, and parainfluenza virus type 1 (Sendai) in 3%. A local production in the CNS of antibodies against any of the viruses studied was found in 71% of multiple sclerosis patients. These included 48, 16, and 7% that produced antibodies to one, two, and three or more viruses, respectively.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372178      PMCID: PMC423007          DOI: 10.1128/iai.10.4.688-694.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1.

Authors:  A M Lerner; C B Lauter; D C Nolan; M J Shippey
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

2.  A new serological technique for identification of adenovirus infections.

Authors:  E Norrby; J van der Veen; A Espmark
Journal:  Proc Soc Exp Biol Med       Date:  1970-07

3.  HL-A antigens and multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

Review 4.  Cerebrospinal fluid immunoglobulins and the central nervous system as an immunological organ particularly in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  W W Tourtellotte
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1971

5.  Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  P Brown; F Cathala; D C Gajdusek; C J Gibbs
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

6.  Measles antibody titers of multiple sclerosis patients and their siblings.

Authors:  J A Brody; J L Sever; A Edgar; J McNew
Journal:  Neurology       Date:  1972-05       Impact factor: 9.910

7.  Virus antibodies in serum specimens from patients with multiple sclerosis, from siblings, and matched controls. A final report.

Authors:  M Panelius; A Salmi; P E Halonen; E Kivalo; U K Rinne; K Penttinen
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

8.  HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12.

Authors:  J Bertrams; E Kuwert
Journal:  Eur Neurol       Date:  1972       Impact factor: 1.710

9.  Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells.

Authors:  P E Halonen; J M Ryan; J A Stewart
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

10.  Appearance and persistence of antibodies against different virus components after regular measles infections.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

View more
  36 in total

1.  Viral antibody in the cerebrospinal fluid of patients with acute central nervous system infections.

Authors:  R Deibel; G D Schryver
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

2.  Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional techniques.

Authors:  B Forghani; N E Cremer; K P Johnson; A H Ginsberg; W H Likosky
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Local synovial synthesis of oligoclonal measles virus antibodies and of smooth muscle antibodies in a case of atypical rheumatoid arthritis.

Authors:  B Vandvik; O J Mellbye; E Norrby
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

4.  Persistent infection of tissue culture cells by RNA viruses.

Authors:  R K Rima; S J Martin
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

5.  The role of the thymus in multiple sclerosis.

Authors:  V D'Andrea; G Meco; F Corvese; P F Baselice; V Ambrogi
Journal:  Ital J Neurol Sci       Date:  1989-02

6.  IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 7.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

8.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

9.  Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.

Authors:  R W Hankins; F L Black
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

10.  Immunoprecipitation of herpes simplex virus type 1 antigens with different antisera and human cerebrospinal fluids.

Authors:  G Pauli; H Ludwig
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.